Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function
about
alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic rolePlacental alpha(2)-adrenoceptors control vascular development at the interface between mother and embryoPharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.Non-adrenergic binding of [3H]atipamezole in rat kidney--regional distribution and comparison to alpha2-adrenoceptorsChronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brainThe anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.[3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.Characterization of imidazoline receptors in blood vessels for the development of antihypertensive agentsCisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonistsSelectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms.Canavanine increases glucose uptake in C2 C12 cells through the activation of imidazoline I-2B receptors.Imidazoline I2 receptors: An update.Localization of I2-imidazoline binding sites on monoamine oxidases.No relationship of I1- and I2-imidazoline binding sites to inhibitory effects of imidazolines on ligand-gated ion channels. An investigation in the adrenal medulla and in neuroblastoma cells.Imidazoline binding sites. Pharmacological and molecular characteristics.I2-imidazoline receptors in the healthy and pathologic human brain.Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine.Molecular and physiological properties of clonidine-displacing substance.Dynamic properties of I2-receptors.Imidazoline receptor agonist drugs: a new approach to the treatment of systemic hypertension.Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine.Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.Relevance of the use of [3H]-clonidine to identify imidazoline receptors in the rabbit brainstem.Changes of imidazoline receptors in spontaneously hypertensive rats.Imidazoline (I2) binding sites in chicken brain.Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.Identification of human I1 receptors and their relationship to alpha 2-adrenoceptors.Affinity isolation of imidazoline binding proteins from rat brain using 5-amino-efaroxan as a ligand.
P2860
Q28142296-F9759FD5-9586-43B7-9EDD-615B652E16E7Q28513384-15AA5CE1-25E9-4364-A500-1C64A4E107CFQ33693033-0FC551ED-35B3-443E-90A5-1524B07BF9B3Q35026368-31BEC02E-BFC0-48E8-8264-85D094C2DBF3Q35041701-8BE03907-8DFF-498C-A812-87460F11422EQ35871470-AFCF2748-C7E5-443C-B83F-0FDD71FA81F8Q35872537-E47C1C21-DEC8-420D-A64F-D04034DBB535Q36329530-1B33D369-5AB0-45E0-A920-A0C86F07E577Q37717807-0DC3136F-E049-4CDB-BBD2-F2B095C5F534Q37761329-A63776E1-9EDA-4BE7-93F5-9839ED593CF2Q38336214-31A06788-C763-4E8E-8039-FBED1CD75577Q38851177-137C7FFC-D9F1-4F97-92B2-43D1953B6054Q39189902-BAE79403-007D-4881-981C-E5063AB3BC8DQ39379564-D6246475-CBB6-4A8F-AEEA-007E30FEEAE3Q40404135-4B365251-CFF0-4E7F-97C4-710F910212F9Q40483859-4EF8A4D9-EC85-4F7C-BB9A-2CD8DF03C01AQ40483894-E0578C18-4026-4CE0-A605-A4BE60B365B9Q40483933-0BDAB505-B351-457C-98E4-173013478B99Q40483936-F75B5BF4-F10C-4D28-84DD-9FA29D8A51C9Q40483970-96B909E5-9AE1-4F71-ACCB-AF456A58E39CQ41148000-FCCC75D8-A712-4DD6-A529-BF259892EC9CQ41835100-3322AEE3-E029-40D1-85B7-0FE0844BAF02Q41861525-F1392310-160A-4B83-86CD-0A5C5CD76325Q41984937-3B2A0C54-1CEC-4A19-898A-0669BD87688CQ42920780-2085CC4C-4D9D-44B1-A7A2-005F8C2337A8Q45381989-A8BB1C78-2375-4394-93C1-572ACEEC063CQ48155189-03B87228-26DB-4D9B-913A-09B504E48ECDQ48155212-CD9E290F-D0C0-41FB-A9DC-FA5AC3138242Q48155235-856DF1B3-D0A3-4B69-A27E-9034282DF186Q48226871-06A39301-302E-41A0-B265-3394632DB78D
P2860
Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Imidazoline binding sites in h ...... rch for physiological function
@ast
Imidazoline binding sites in h ...... rch for physiological function
@en
type
label
Imidazoline binding sites in h ...... rch for physiological function
@ast
Imidazoline binding sites in h ...... rch for physiological function
@en
prefLabel
Imidazoline binding sites in h ...... rch for physiological function
@ast
Imidazoline binding sites in h ...... rch for physiological function
@en
P2093
P2860
P1476
Imidazoline binding sites in h ...... rch for physiological function
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1992.TB14300.X
P407
P577
1992-05-01T00:00:00Z